Philip Gotwals
Direktor/Vorstandsmitglied bei CAPRICOR THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Philip J.
Gotwals is currently an Independent Director at Capricor Therapeutics, Inc. He previously held positions as a Senior Director-Early Development at Biogen, Inc. from 2004 to 2006, Vice President-Business Development & Licensing at Novartis Institutes for Biomedical Research, Inc. from 2009 to 2023, and Vice President-Program Management at Altus Pharmaceuticals, Inc. from 2006 to 2009.
He was also a Partner at Redsky Partners LLC until 2005.
Dr. Gotwals obtained his undergraduate degree from Amherst College and his doctorate from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Philip Gotwals
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.07.2023 |
Ehemalige bekannte Positionen von Philip Gotwals
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2023 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.2009 |
| BIOGEN INC. | Corporate Officer/Principal | 01.09.2006 |
Redsky Partners LLC
 Redsky Partners LLC Financial ConglomeratesFinance Founded in 2002, RedSky Partners LLC is a Minneapolis, Minnesota-based hedge fund firm. | Corporate Officer/Principal | - |
Ausbildung von Philip Gotwals
| University of California, Berkeley | Doctorate Degree |
| Amherst College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Redsky Partners LLC
Redsky Partners LLC Financial ConglomeratesFinance Founded in 2002, RedSky Partners LLC is a Minneapolis, Minnesota-based hedge fund firm. | Finance |
